Skip to content

Clinical trials

Gastrointestinal Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20161
20172
20183
20202
20214
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Ellodi Pharmaceuticals, LP2
ImmusanT, Inc.2
Pfizer2
The University of Queensland2
AbbVie1
Ethicon, Inc.1
InDex Pharmaceuticals1
Innovent Biologics (Suzhou) Co. Ltd.1
Princess Alexandra Hospital, Brisbane, Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases19
Digestive System Diseases7
Intestinal Diseases7
Esophageal Diseases5
Gastroenteritis5
Colonic Diseases4
Digestive System Neoplasms4
Eosinophilia4
Eosinophilic Esophagitis4
Esophagitis4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.